Organon & Co. Employee Count
The employee counts Organon & Co. states in its annual reports on SEC EDGAR, each as filed.
- 2023-12-31: Employees (as filed) 10,000; Filing 2024-02-26; Lease expense per employee $6,700.00.
- 2022-12-31: Employees (as filed) 10,000; Filing 2023-02-27; Lease expense per employee $6,100.00.
- 2021-12-31: Employees (as filed) 9,300; Filing 2022-03-21; Lease expense per employee $7,096.77.
- Available history
- 2021-12-31 to 2023-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2023-12-31 | 10,000 | 2024-02-26 | $6,700.00 total lease cost |
| 2022-12-31 | 10,000 | 2023-02-27 | $6,100.00 total lease cost |
| 2021-12-31 | 9,300 | 2022-03-21 | $7,096.77 total lease cost |
Headcount breakdown as filed
| Fiscal year end | Employees | Xbrl:DisposalGroupClassification | Xbrl:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperations | Xbrl:SubsequentEventType | Filing |
|---|---|---|---|---|---|
| 2025-12-31 | DisposalGroupNotDiscontinuedOperations: 100 | Jada: 100 | SubsequentEvent: 100 | 2026-02-24 “” |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |